SCHEMBL965069

SCHEMBL965069

Cc1cc(OC(F)(F)F)ccc1C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.46
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
PIM1 P11309 1/20 0.43
GRIN2B Q13224 1/20 0.43
MAPK8 P45983 1/20 0.42
PPARG P37231 1/20 0.42
PPARD Q03181 1/20 0.42
PPARA Q07869 1/20 0.42
FFAR4 Q5NUL3 2/20 0.41
EPHX2 P34913 1/20 0.41
IDH1 O75874 1/20 0.41
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 1/20 0.40
EPHX1 P07099 1/20 0.40
GPR3 P46089 1/20 0.40
IGF2BP2 Q9Y6M1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7999913 0.98 CHEK1 (0.45) CHEK1SLC6A2SLC6A4PIM1GRIN2B
SCHEMBL12569554 0.87 CHEK1 (0.46) CHEK1SLC6A2SLC6A4PIM1GRIN2B
SCHEMBL966871 0.85 RXRB (0.50) PIM1PPARGPPARDPPARAFFAR4
SCHEMBL6518415 0.84 CHEK1 (0.49) CHEK1SLC6A2SLC6A4PIM1MAPK8
SCHEMBL31168096 0.83 ABL1 (0.47) PPARGPPARDPPARAFFAR4EPHX2
SCHEMBL4666472 0.83 FFAR4 (0.44) PIM1PPARGPPARDPPARAFFAR4
SCHEMBL6337205 0.82 LMNA (0.47) CHEK1SLC6A2SLC6A4FFAR4MKNK1
SCHEMBL2314619 0.81 CHEK1 (0.47) CHEK1SLC6A2SLC6A4PIM1MAPK8
SCHEMBL22092981 0.81 DGAT1 (0.51) CHEK1SLC6A2SLC6A4PIM1MAPK8
SCHEMBL30236136 0.81 CHEK1 (0.47) CHEK1SLC6A2SLC6A4PIM1MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565228-A2 COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS Kojin Therapeutics, Inc. (US) 2025-06-11 EP disclosed
WO-2024030960-A2 COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS Kojin Therapeutics, Inc. (US) 2024-02-08 WO disclosed
CN-101031557-B Substituted quinolones AICURIS GMBH & CO KG 2011-07-27 CN disclosed
US-7977349-B2 Substituted quinolones III AICURIS GMBH & CO. KG (DE) 2011-07-12 US disclosed
US-7977349-B2 Substituted quinolones III AICURIS GMBH & CO. KG (DE) 2011-07-12 US disclosed
US-7977349-B2 Substituted quinolones III AICURIS GMBH & CO. KG (DE) 2011-07-12 US disclosed
EP-1994020-B1 Substituted quinolones III AICURIS GMBH & CO KG (DE) 2011-06-22 EP disclosed
EP-1994020-B1 Substituted quinolones III AICURIS GMBH & CO KG (DE) 2011-06-22 EP disclosed
US-7867992-B2 such as 1-Cyclopropyl-N-(2,4-dichlorobenzyl)-6-fluoro-8-methoxy-7-[3-methyl-4-(2-{[(methylamino)carbonyl]amino}-2-oxoethyl)piperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxamide, used for the treatment and/or prophylaxis of viral diseases or infections, particularly against cytomegaloviruses AICURIS GMBH & CO. KG (DE) 2011-01-11 US disclosed
US-7867992-B2 such as 1-Cyclopropyl-N-(2,4-dichlorobenzyl)-6-fluoro-8-methoxy-7-[3-methyl-4-(2-{[(methylamino)carbonyl]amino}-2-oxoethyl)piperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxamide, used for the treatment and/or prophylaxis of viral diseases or infections, particularly against cytomegaloviruses AICURIS GMBH & CO. KG (DE) 2011-01-11 US disclosed
WO-2007003308-A1 SUBSTITUTED QUINOLONES II AICURIS GMBH & CO. KG (DE) 2007-01-11 WO disclosed
WO-2007003308-A1 SUBSTITUTED QUINOLONES II AICURIS GMBH & CO. KG (DE) 2007-01-11 WO disclosed
WO-2006008046-A1 SUBSTITUTED QUINOLONES AICURIS GMBH & CO. KG (DE) 2006-01-26 WO disclosed
EP-1178802-A4 CYCLIC AMIDINES USEFUL AS NMDA NR2B ANTAGONISTS MERCK & CO INC (US) 2003-06-04 EP disclosed
US-6376530-B1 A N-METHYLASPARTIC ACID ANTAGONIST; NERVOUS SYSTEM DISORDERS, ANALGESICS MERCK & CO., INC. 2002-04-23 US disclosed
EP-1178802-A1 CYCLIC AMIDINES USEFUL AS NMDA NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-02-13 EP disclosed
EP-1159263-A1 NOVEL SULFONAMIDE COMPOUNDS AND USES THEREOF Merck & Co., Inc. (US) 2001-12-05 EP disclosed
WO-2000067755-A1 CYCLIC AMIDINES USEFUL AS NMDA NR2B ANTAGONISTS MERCK & CO., INC. (US) 2000-11-16 WO disclosed
WO-2000050391-A1 NOVEL SULFONAMIDE COMPOUNDS AND USES THEREOF MERCK & CO., INC. (US) 2000-08-31 WO disclosed
US-5846990-A Substituted biphenyl isoxazole sulfonamides BRISTOL-MYERS SQUIBB CO. (US) 1998-12-08 US disclosed